SEARCH

SEARCH BY CITATION

References

  • Andiné P., Rudolphi K. A., Fredholm B. B. and Hagberg H. (1990) Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmacol. 100, 814818.
  • Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A. and Nicotera P. (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961973.
  • Batalha V. L., Pego J. M., Fontinha B. M., Costenla A. R., Valadas J. S., Baqi Y., Radjainia H., Müller C. E., Sebastião A. M. and Lopes L. V. (2012) Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Mol. Psychiatry. doi: 10.1038/mp.2012.8. (Epub ahead of print)
  • Bayatti N., Hermann H., Lutz B. and Behl C. (2005) Corticotropin-releasing hormone-mediated induction of intracellular signaling pathways and brain-derived neurotrophic factor expression is inhibited by the activation of the endocannabinoid system. Endocrinology 146, 12051213.
  • Bittencourt J. C., Vaughan J., Arias C., Rissman R. and a, Vale, W.W. & Sawchenko P.E. (1999) Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285312.
  • Blank T., Nijholt I., Grammatopoulos D. K., Randeva H. S., Hillhouse E. W. and Spiess J. (2003) Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J. Neurosci. 23, 700707.
  • Bonfoco E., Krainc D., Ankarcrona M., Nicotera P. and Lipton S. A. (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 71627166.
  • Canas P. M., Porciuncula L. O., Cunha G. M., Silva C. G., Machado N. J., Oliveira J. M., Oliveira C. R. and Cunha R. A. (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 29, 1474114751.
  • Chalmers D. T., Lovenberg T. W. and De Souza E. B. (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 63406350.
  • Chen F. M., Bilezikjian L. M., Perrin M. H., Rivier J. and Vale W. (1986) Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res. 386, 4957.
  • Chen R., Lewis K. and a, Perrin, M.H. & Vale W.W. (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl Acad. Sci. USA 90, 89678971.
  • Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S. and Schwarzschild M. A. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 91929200.
  • Chen Y., Bender R. A., Frotscher M. and Baram T. Z. (2001) Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J. Neurosci. 21, 71717181.
  • Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M and Baram TZ. (2004a) Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience 126, 533540.
  • Chen X. Q., Du J. Z. and Wang Y. S. (2004b) Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine. Regul. Pept. 119, 221228.
  • Choi D. W., Maulucci-Gedde M. and Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357368.
  • Cunha G. M., Canas P. M., Oliveira C. R. and Cunha R. A. (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141, 17751781.
  • Dall'Igna O. P., Porciuncula L. O., Souza D. O., Cunha R. A. and Lara D. R. (2003) Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br. J. Pharmacol. 138, 12071209.
  • Dias R. B., Ribeiro J. A. and Sebastião A. M. (2012) Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A(2A) receptors. Hippocampus 22, 276291.
  • Elliott-Hunt C. R., Kazlauskaite J., Wilde G. J., Grammatopoulos D. K. and Hillhouse E. W. (2002) Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus. J. Neurochem. 80, 416425.
  • Estus S., Tucker H. M., van Rooyen C., Wright S., Brigham E. F., Wogulis M. and Rydel R. E. (1997) Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant “apoptotic” pattern of gene induction. J. Neurosci. 17, 77367745.
  • Fischman A. J. and Moldow R. L. (1982) Extrahypothalamic distribution of CRF-like immunoreactivity in the rat brain. Peptides 3, 149153.
  • Fox M. W., Anderson R. E. and Meyer F. B. (1993) Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke 24, 10721075.
  • Fredholm B. B., AP I. J., Jacobson K. A., Klotz K. N. and Linden J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527552.
  • Fredholm B. B., Chen J. F., Cunha R. A., Svenningsson P. and Vaugeois J. M. (2005) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191270.
  • Grammatopoulos D. K., Randeva H. S., Levine M. A., Kanellopoulou K. A. and Hillhouse E. W. (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 76, 509519.
  • Gulyas J., Rivier C., Perrin M., Koerber S. C., Sutton S., Corrigan A., Lahrichi S. L. and Craig, a G., Vale, W. & Rivier, J. (1995) Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl Acad. Sci. USA 92, 1057510579.
  • Kemppainen S., Rantamäki T., Jerónimo-Santos A. et al. (2012) Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol. Aging 33, 11221139.
  • Latini S. and Pedata F. (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79, 463484.
  • Leonard A. S. and Hell J. W. (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272, 1210712115.
  • Leveille F., El Gaamouch F., Gouix E., Lecocq M., Lobner D., Nicole O. and Buisson A. (2008) Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 22, 42584271.
  • Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613622.
  • Lopes L. V., Cunha R. A., Kull B., Fredholm B. B. and Ribeiro J. A. (2002) Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112, 319329.
  • Lovenberg T. W., Liaw C. W., Grigoriadis D. E., Clevenger W., Chalmers D. T., De Souza E. B. and Oltersdorf T. (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA 92, 836840.
  • Lowry O. H., Rosebrough N. J., Farr A. L.and Randall R. J. (1951) Protein measurement with the Folin Phenol Reagent, J. Biol. Chem. 193, 265275.
  • Melani A., Gianfriddo M., Vannucchi M. G., Cipriani S., Baraldi P. G., Giovannini M. G. and Pedata F. (2006) The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 1073–1074, 470480.
  • de Mendonça A., Sebastião A. M. and Ribeiro J. A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Brain Res. Rev. 33, 258274.
  • Monopoli A., Lozza G., Forlani A., Mattavelli A. and Ongini E. (1998) Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport 9, 39553959.
  • Nicotera P., Leist M. and Manzo L. (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20, 4651.
  • Pedersen W. A., McCullers D., Culmsee C., Haughey N. J., Herman J. P. and Mattson M. P. (2001) Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease. Neurobiol. Dis. 8, 492503.
  • Pedersen W. A., Wan R., Zhang P. and Mattson M. P. (2002) Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22, 404412.
  • Popoli P., Frank C., Tebano M. T., Potenza R. L., Pintor A., Domenici M. R., Nazzicone V., Pèzzola A. and Reggio R. (2003) Modulation of glutamate release and excitotoxicity by adenosine A2A receptors. Neurology 61, S69S71.
  • Radulovic J., Rühmann A., Liepold T. and Spiess J. (1999) Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J. Neurosci. 19, 50165025.
  • Rebola N., Porciuncula L. O., Lopes L. V., Oliveira C. R., Soares-da-Silva P. and Cunha R. A. (2005a) Long-term effect of convulsive behavior on the density of adenosine A1 and A 2A receptors in the rat cerebral cortex. Epilepsia 46(Suppl 5), 159165.
  • Rebola N., Rodrigues R. J., Oliveira C. R. and Cunha R. A. (2005b) Different roles of adenosine A1, A2A and A3 receptors in controlling kainate-induced toxicity in cortical cultured neurons. Neurochem. Int. 47, 317325.
  • Rissman R. A, Lee K.-F., Vale W. and Sawchenko P. E. (2007) Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J. Neurosci. 27, 65526562.
  • Swanson L. W., Sawchenko P. E., Rivier J. and Vale W. W. (1983) Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat barin: an immunohistochemical study. Neuroendocrinology 36, 165186.
  • Szabadfi K., Atlasz T., Reglodi D., Kiss P., Dányádi B., Fekete E. M., Zorrilla E. P., Tamás A., Szabó K. and Gábriel R. (2009) Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat. Neurosci. Lett. 455, 4245.
  • Tamura Y., Sato Y., Yokota T., Akaike A., Sasa M. and Takaori S. (1993) Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons. J. Pharmacol. Exp. Ther. 265, 10171025.
  • Tan S.-E., Wenthold J. and Soderlingl R. (1994) Phosphorylation of AMPA-type glutamate receptors by calcium / protein kinase II and protein kinase C in cultured hippocampal neurons. J. Neurosci. 14, 11231129.
  • Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA 76, 43504354.
  • Vale W., Spiess J., Rivier C. and Rivier J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 13941397.
  • Vaughan J., Donaldson C., Bittencourt J. et al. (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287292.